Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/7/2025

SLE and DVT Risk

Magnitude of Risk

  • SLE is an independent risk factor for both arterial and venous thrombotic events, according to the MMWR Recommendations and Reports and Annals of the Rheumatic Diseases 1, 2

Risk Stratification and Clinical Implications

  • The American College of Physicians and other guideline societies imply that SLE patients with positive antiphospholipid antibodies, particularly those with high-risk profiles, may benefit from low-dose aspirin for primary thrombosis prevention, as suggested by Annals of the Rheumatic Diseases 2, 4, 5
  • The European League Against Rheumatism recommends that additional anticoagulant treatment with low-molecular-weight heparin should be considered during high-risk periods such as surgery or prolonged immobilization, as stated in Annals of the Rheumatic Diseases 2, 4
  • For SLE patients who develop DVT, the American Heart Association suggests that vitamin K antagonists (warfarin with target INR 2-3) are preferred over direct oral anticoagulants (DOACs), according to Praxis Medical Insights and Annals of the Rheumatic Diseases 2, 4, 6

Additional Risk Factors and Prevention

  • Persistent high disease activity, lupus nephritis, glucocorticoid use, and nephrotic syndrome with hypogammaglobulinemia are SLE-related factors that increase thrombotic risk, as reported by Annals of the Rheumatic Diseases 2, 4, 5
  • The U.S. Medical Eligibility Criteria assigns Category 4 (unacceptable health risk) to combined hormonal contraceptives in SLE patients with positive or unknown antiphospholipid antibodies, as stated in MMWR Recommendations and Reports 1, 7
  • Hydroxychloroquine should be maintained as cornerstone therapy, as it reduces disease flares and has protective effects against thrombosis, according to Praxis Medical Insights 6, 8

REFERENCES

5

Stroke Prevention in SLE Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

7

Management of Lupus Patients on Apixaban [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025